Ze-yang Ding
Tongji Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ze-yang Ding as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:28 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07489768 · GNB4 and Riplet Gene Methylation Combined Detection Kit for Hepatocellular Carcinoma Recurrence MonitoringTongji Hospital · not yet recruiting · Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Recurrent · principal investigator
- Ph2NCT07053150 · A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ± Chemotherapy in Patients With Advanced Digestive System TumorsTongji Hospital · not yet recruiting · Advanced Digestive System Tumor · study chair
- Ph2NCT06954116 · Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of RecurrenceTongji Hospital · recruiting · Resectable Hepatocellular Carcinoma With High Risk of Recurrence · study chair
- N/ANCT06653062 · Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence SurveillanceTongji Hospital · recruiting · Hepatocellular Carcinoma (HCC) · study chair
- N/ANCT06653127 · Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence SurveillanceTongji Hospital · recruiting · Biliary Tract Cancer · study chair
- N/ANCT06194695 · DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic CholangiocarcinomaZe-yang Ding, MD · unknown · Cholangiocarcinoma Non-resectable · principal investigator
- Ph2NCT06192797 · Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic CholangiocarcinomaTongji Hospital · recruiting · Cholangiocarcinoma Non-resectable · study chair
- Ph2NCT06192784 · Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic CholangiocarcinomaTongji Hospital · unknown · Cholangiocarcinoma Non-resectable · study chair
- Ph2NCT06187961 · HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular CarcinomaTongji Hospital · recruiting · Hepatocellular Carcinoma Non-resectable · study chair
- N/ANCT05717738 · Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular CarcinomaTongji Hospital · unknown · Hepatocellular Carcinoma Non-resectable · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:28 UTC. The ranking covers the 200 most relevant of 166 PubMed records, and a shared surname and initials can bring in a namesake. All 166 on PubMed
- Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.N Engl J Med · 2023818 citationsRCR 112.1
- Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.Nat Med · 2020447 citationsRCR 17.1
- Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer.Signal Transduct Target Ther · 2021240 citationsRCR 11.5
- Functional electrical stimulation cycling improves body composition, metabolic and neural factors in persons with spinal cord injury.J Electromyogr Kinesiol · 2009167 citationsRCR 6.5
- Quantitative diffusion tensor MRI-based fiber tracking of human skeletal muscle.J Appl Physiol (1985) · 2007114 citationsRCR 4.5
- 109 citationsRCR 3.9
- 103 citationsRCR 5.7
- Attention Bias Modification training in individuals with depressive symptoms: A randomized controlled trial.J Behav Ther Exp Psychiatry · 201597 citationsRCR 4.7
- Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.Bull World Health Organ · 200196 citationsRCR 2.6
- Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma.Ann Surg Oncol · 201293 citationsRCR 2.2